- Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 – SCOTTSDALE, Ariz., March 13, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: …
Net Revenue Increased 8.7% and 4.6% for the Fourth Quarter and Full Year 2024, Respectively Pre-Recorded Earnings Call Webcast Available on Investor Relations Website LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF …
FORT MYERS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or “the Company”) (Nasdaq: ALCO) today announced a major milestone in its strategic transformation with the filing of a development application for the first of two villages (“ …
Fourth Quarter Comparable Sales Increased 5.9% Fourth Quarter Gross Margin Increased 190 Basis Points to 36.2% Fourth Quarter Earnings Per Share Improved to $0.78 from ($1.73) First Quarter-To-Date Comparable Sales up 4.3%, Led by North America Up 6.4% …
BOULDER, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) (“Gaia” and/or the “Company”), a conscious media and community company, will be holding one-on-one meetings at the 37th Annual ROTH Conference from March 16-18, 2025, at the …
SANTA CLARA, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the expansion of its Cloud-Scale Interop Lab to …
Lima, March 13, 2025 (GLOBE NEWSWIRE) -- Lima, PERU, March 13th, 2025 – Credicorp Ltd. (“Credicorp”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia, and Panama, announced today …
UNIONDALE, N.Y., March 13, 2025 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the closing of a $1.15 billion repurchase facility (the "Repurchase Facility"), with JPMorgan Chase Bank, N.A. In connection with this …
PHILADELPHIA, PA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Results Driven Marketing, LLC proudly announces that it holds the official trademark for Turning Clicks Into Clients®, as conferred by the United States Patent & Trademark …
OTTAWA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- Today, the Government of Canada announced close to $4.4 million in research infrastructure funding through the Canada Foundation for Innovation (CFI) to support 17 Canada Research Chairs (CRCs) at 12 …
OTTAWA, Ontario, 13 mars 2025 (GLOBE NEWSWIRE) -- Aujourd’hui, le gouvernement du Canada a annoncé un investissement de près de 4,4 millions de dollars dans l’infrastructure de recherche du pays par l’entremise de la Fondation canadienne pour l’innovation …
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments Secured $14.3 million net proceeds in financings, …
Momentum Builds Across Programs with Key Data Milestones Expected in 2025 Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Ongoing Pivotal Phase 2 ALPHA3 Trial Advancing with Site Activation and Patient …
MITCHEL FIELD, N.Y., March 13, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the three and nine months ended January 31, 2025, of approximately $18.9 million and $49.8 million, …
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT™ study reinforces its favorable safety profile. Publication in Science …
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio,” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025 In parallel, the Company continues to analyze data and explore opportunities for LYR-210 in CRS patient cohort with nasal polyps …
MIAMI, FL, March 13, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced that its 2025 Annual Meeting …
DENVER, March 13, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the fourth quarter and full year ended …
Small businesses in Washington rely on professional tax preparation support to ensure compliance and maximize tax savings. MIAMI, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- With the U.S. tax filing deadline rapidly approaching, …
02 days 16:18:38
